JPRN-UMIN000013329已完成2 期
Phase2 study of Carboplatin / Nab-paclitaxel + Bevacizumab to non-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussion - Phase2 study of CBDCA / Nab-PAC + Bevacizumab to non-small-cell lung cancer with malignant pleural efussion
Osaka Prefectural Medical Center for Respiratory and Allergic diseases0 个研究点目标入组 20 人开始时间: 2014年3月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of pleurodesis or pleural effusion drainage 2)Severe infection except for non-active hepatitis C 3)Fever more than 38 degree 4)Severe comorbidity (heart failure/kidney failure/hepatic failure/uncontrollable diabetes/uncontrollable hypertension, etc) 5)Active double cancer 6)Symptomatic brain metastasis 7)History of hemoptysis with 2.5mL or more 8)Pericardial effusion requiring drainage 9)Interstitial pneumonia or pulmonary fibrosis detectable on X ray 10)History of drug sensitivity 11)Pregnant or lactating women 12)Psychiatric disease or mental trouble 13)Continuing administration of steroid 14)Evaluated to be ineligible by a physician for other reasons
研究者
相似试验
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
已完成
2 期
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
招募中
1 期
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
已完成
2 期
Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancerJPRN-UMIN000011681Gifu Municipal Hospital32
已完成
2 期
Phase2 study of Carboplatin / Paclitaxel + Bevacizumab to non-small-cell lung cancer (non-squamous cell carcinoma) with pleural efussion in stage4non-small-cell lung cancer (non-squamous cell carcinoma) with pleural efussion in stage4JPRN-UMIN000005284Osaka Prefectural Medical Center for Respiratory and Allergic diseases20